Semi-Automated Detection of the Factor V Mutation by Allele Specific Amplification and Capillary Electrophoresis

summary

Recently a point mutation (G1691A) in the coagulation factor V gene was shown to cause resistance for cleavage by activated protein C.The mutation is associated with an increased thrombotic risk and thus- far the most common genetic cause of thrombophilia.Current techniques to investigate the single base pair mutation at the DNA level use an assay based upon the polymerase chain reaction followed by restriction enzyme digestion or Southern blotting and allele specific probing.The method we describe here consists of a single PCR in which two specially designed allele specific primers and two consensus primers were used in one reaction to distinguish between homozygous normal,heterozygous and homozygous mutant individuals.Amplification products were analysed using Capillary Electrophoresis and on line UV monitoring.

The Allele Specific Amplification Protocol and subsequent CE analysis (ASAP-CE) is a convenient,fast,automated and highly reproducible method that can be used in a routine laboratory setting.

• References

• 1 Dittman WA, Majerus PW. Structure and function of Thrombomodulin: a natural anticoagulant. Blood 1990; 75 nr [phone]
• 2 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unreeogni/ed mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sei USA 1993; 90: 1004-1008
• 3 Bertina RM, Koeleman BP C, Koster T, Rosendaal FR, Dirven RJ, de Ron-de H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 4 Voorberg J, Roelse J, Koopman R, Buller H, Berends F, ten Cate JW, Mertens K, van Mourik JA. Association of idiopathic venous thromboembolism withsingle point-mutation at Arg⁵⁰⁶of factor V. Lancet 1994; 343: 1535-1536
• 5 Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg⁵⁰⁶Gln mutation in factor Va. Lancet 1994 343: 1361-1362
• 6 Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994; 91: 1396-1400
• 7 Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332 (14) 912-917
• 8 Miller SA, J. Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nuc Acid Res 1988; 16: 1215
• 9 cDNA sapience of factor V gene HSFAV, acc nr M 16967 (Genbank).
• 10 Zφller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343: 1536-1538
• 11 Norby S, Lestienne P, Nelson I, Rosenberg T. Mutation detection in Leber’s hereditary optic neuropathy by PCR with allele-specific priming. Biochem Biophys Res Commun 1991; 175 (02) 631-636